Drug induced nightmares - An etiology based review

Human Psychopharmacology

Volumn 18, Issue 1, 2003, Pages 59-67

  Pagel, J F ^a   Helfter, P ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Parkview Medical Center   (United States)

Author keywords

Acetylcholine; Anesthetics; Dopamine; Dreaming; GABA; Histamine; Nightmare; Norepinephrine; Serotonin

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE DERIVATIVE; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; BUSPIRONE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOMIPRAMINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUVOXAMINE; HISTAMINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NEUROLEPTIC AGENT; NEUROTRANSMITTER; NORADRENALIN; PAROXETINE; PERGOLIDE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

BRAIN ELECTROPHYSIOLOGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DREAMING; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HUMAN; IMMUNE RESPONSE; NIGHTMARE; PRIORITY JOURNAL; PROBABILITY; REM SLEEP DEPRIVATION; REVIEW; THEORY;

CAUSALITY; CLINICAL TRIALS; DATA COLLECTION; DREAMS; HUMANS; NEUROTRANSMITTER AGENTS; PHARMACEUTICAL PREPARATIONS;

EID: 0037276182     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.465     Document Type: Review

References (55)

1. Ansoms A, et al. 1991. Zopiclone or lometazepam in the treatment of insomnia and the effect on behavior and mood during the post-alcoholism withdrawal period. Curr Ther Res 49: 54-64.
2. Baekeland F, Lasky R. 1968. The morning recall of rapid eye movement period reports given earlier in the night. J Nerv Ment Dis 147: 570-579.
3. Bixler EO, Kales A, Soldatos CR, Kales JD, Healey S. 1979. Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry 136: 1257-1262.
4. Brismar K, Motgensen L, Wetterberg L. 1987. Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs. Acta Med Scand 221: 155-158.
5. Cohen DB. 1979. Sleep and Dreaming: Origins, Nature and Function. Pergamon: New York.
6. Coupland NJ, Bell CJ, Potokar JP. 1996. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 16: 356-362.
7. Dimsdale J, Newton R. 1991. Cognitive effects of beta-blockers. J Psychosom Res 36: 229-236.
8. Ekblad S, Roth G. 1997. Diagnosing posttraumatic stress disorder in multicultural patients in a Stockholm psychiatric clinic. J Nerv Mental Dis 185: 102-107.
9. Fawzi MC, Pham T, Lin L, et al. 1997. The validity of posttraumatic stress disorder among Vietnamese refugees. J Trauma Stress 10: 101-108.
10. Foulkes D. 1985. Dreaming: A Cognitive-Psychological Analysis. Lawrence Erlbaum Associates: Hillsdale, NJ.
11. Francis A. (Chair-Task Force on DSM-IV). 1994. DSM-IV-Diagnostic and Statistical Manual of Mental Disorders (4th edn). American Psychiatric Association: Washington, DC.
12. Grillon C, Morgan CA, Southwick SM, Davis M, Charney DS. 1996. Baseline startle amplitude and pre-pulse inhibition in Vietnam veterans with posttraumatic stress disorder. Psychiatry Res 64: 169-178.
13. Gursky J, Krahn L. 2000. The effects of antidepressants on sleep: a review. Harvard Rev Psychiatry 8: 298-306.
14. Hobson JA, Steriade M. 1986. The neuronal basis of behavioral state control: internal regulatory systems of the brain. In Handbook of Psychology, Bloom F (ed.), Mountcastle V (series ed.). American Physiological Society: Washington, DC, IV(14): 701-823.
15. Hobson JA. 1994. The Chemistry of Conscious States. Little, Brown and Company: Boston.
16. Hobson JA. 1999. Dreaming as Delerium. MIT Press.
17. Jaffe SE. 2000. Sleep and infectious disease. In Principles and Practice of Sleep Medicine (Vol. 3), Kryger M, Roth T, Dement W (eds). W. B. Saunders: Philadelphia; 1093-1102.
18. Jouvet M. 1999. The Paradox of Sleep: The Story of Dreaming. MIT Press: Cambridge.
19. Klink M, Quan SF. 1987. Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airway diseases. Chest 91: 540-546.
20. Knill RL, Moote CA, Skinner MI, Rose EA. 1990. Anesthesia with abdominal surgery leads to intense REM sleep during the first postoperative week. Anesthesiology 73: 52-61.
21. Krakow B, Neidhardt J. 1992. Conquering Bad Dreams and Nightmares: A Guide to Understanding, Interpretation and Cure. Berkley Books: New York.
22. Krissel J, Dick WF, Leyser KH, Gervais H, Brockerhoff P, Schranz D. 1994. Thiopentone, thiopentone/ketamine, and ketamine for induction of anesthesia in caesarean section. Eur J Anaesthesiol 11: 115-122.
23. Krueger JM, Fang J. 2000. Host defense. In Principles and Practice of Sleep Medicine (Vol. 3), Kryger M, Roth T, Dement W (eds). W. B. Saunders Co: Philadelphia; 255-265.
24. Krueger JM, Kubillis S, Shoham S, et al. 1986. Enhancement of slow wave sleep by endotoxin and libid A. Am J Physiol 251: R591-R597.
25. Lepkifker E, Dannon PN, Iancu I, Ziv R, Kotler M. 1995. Nightmares related to fluoxetine treatment. Clin Neuropharmacol 18: 90-94.
26. Mallick BN, Kaur S, Saxena. 2001. Interactions between cholinergic and GABAnergic neurotransmitters in and around the locus coeruleus for the induction and maintenance of rapid eye movement sleep. Neuroscience 104: 467-485.
27. Marsh SCU, Schaefer HG, Tschan C, Meier B. 1992. Dreaming and anesthesia: total i.v. anaesthesia with propofol versus balanced volatile anaesthesia with enflurane. Eur J Anaesthesiol 9: 331-333.
28. McCarley R. 1982. REM Sleep and depression: common neurobiological control mechanisms. Am J Psychiatry 139: 565-570.
29. McEvoy GK (ed.). 2002. Cardiac drugs. In AHFS Drug Information. American Society of Health Systems Pharmacists, Inc: Bethesda, MD, 24: 04.
30. Mellman T, Kulick-Bell R, Ashlock LE, Nolan B. 1995. Sleep events among veterans with combat-related posttraumatic stress disorder. Am J Psychiatry 152: 110-115.
31. Moffitt A, Kramer M, Hoffman R (eds). 1993. The Functions of Dreaming. State University of New York Press: Albany, NY.
32. Naranjo CA, Busto U, Sellers EM, et al. 1981. A method for estimating the probability of adverse drug interactions. Clin Pharmacol Ther 30: 239-245.
33. Oxorn D, et al. 1997. The effects of midazolam on propofol-induced anesthesia: propofol dose requirements, mood profiles, and perioperative dreams. Anesth Analg 85: 553-559.
34. Pace-Schott E, Gersh T, Silvestri R, Stickgold R, Salzman C, Hobson JA. 1999. Effects of serotonin reuptake inhibitors (SSRI) on dreaming in normal subjects. Sleep 22(Suppl. 1): H278D.
35. Pace-Schott E, Gersh T, Silvestri R, Stickgold R, Salzman C, Hobson JA. 2000. Enhancement of subjective intensity of dream features in normal subjects by the SSRIs paroxetine and fluvoxamine. Behav Brain Sci 23(6): 980-984.
36. Pace-Schott EF. Recent findings on the neurobiology of sleep and dreaming. In C.U.P. book Sleep and Dreaming: Scientific Advances and Reconsiderations Based on BBS Special Issue on Sleep and Dreaming (v. 23, December 2000).
37. Pagel JF. 1986. The diagnosis and treatment of insomnia. Am Fam Physic 35: 191-196.
38. Pagel JF. 1993. Modeling drug actions on electrophysiologic effects produced by EEG modulated potentials. Hum Psychopharmacol 8: 211-216.
39. Pagel JF (Chairman), Blagrove M, Levin R, States B, Stickgold B, White S. 1999. Defining dreaming - a paradigm for comparing interdisciplinary studies of dream. Bull Am Acad Sleep Med 6: 34.
40. Pagel JF, Blagrove M, Levin R, States B, Stickgold B, White S. 2001. Definitions of dream - a paradigm for comparing field descriptive specific studies of dream. Dreaming 11: 195-202.
41. Pagel JF. 1996. Pharmacologic alteration of sleep and dreams - a clinical framework for using the electrophysiological and sleep stage effects of psychoactive medications. Hum Psychopharmacol 11: 217-224.
42. Pagel JF. 2000. Nightmares and disorders of dreaming. Am Family Physic 61: 2037-2042.
43. Perry E, Perry R. 1995. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cognit 28: 240-258.
44. Ross RJ, Ball WA, Sullivan KA, Caroff SN. 1989. Sleep disturbance as the hallmark of posttraumatic stress disorder. Am J Psychiatry 146: 697-707.
45. Schenck CH, Mahowald MW. 1996. REM sleep parasomnias. Neurol Clinics 14: 697-720.
46. Sifton DW. (ed.). 2002. Physicians' Desk Reference. Medical Economics Co. Inc: Montvale, NJ.
47. Solms M. 1997. The Neuropsychology of Dreams - A Clinico-Anatomical Study. Lawrence Erlbaum Associates: Mahwah, NJ.
48. Stacy M. 1999. Managing late complications of Parkinson's disease. Med Clin N Am 83: 469-481.
49. Terr LC. 1987. Nightmares in children. In Sleep and Its Disorders in Children, Guilleminault C (ed.). Raven: New York.
50. Thompson D, Pierce D. 1999. Drug induced nightmares. Ann Pharmacother 33: 93-96.
51. Thorpy M (ed.). 1997. American Sleep Disorders Association, The International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual. American Sleep Disorders Association: Rochester, MN.
52. Van Moffaert M, et al. 1990. Comparison of zopiclone and flunitrazepam in the treatment of insomnia in depressed patients. Curr Ther Res 48: 140-153.
53. Wood JM, Bootzin RR. 1990. The prevalence of nightmares and their independence from anxiety. J Abnorm Psychol 99: 64-68.
54. Xi MC, Morales FR, Chase MH. 1999. Evidence that wakefulness and REM sleep are controlled by a GABAergic pontine mechanism. J Neurophysiol 82: 2015-2019.
55. Yehuda R, McFarlane AC. 1995. Conflict between current knowledge about posttraumatic stress disorder and its original conceptual basis. Am J Psychiatry 152: 1705-1713.